Chinese biotech firms outpace West in strategic sector, urges Pax Biologica

A Foreign Policy analysis argues Chinese companies are displacing Western competitors in biotechnology, a strategically vital industry. The piece calls for a Western-led 'Pax Biologica' framework to counter this shift, framing biotech as a new arena of great-power competition. The claim is an opinion-driven assessment of competitive dynamics, not a confirmed event.